NRX Pharmaceuticals, Inc. Common Stock

NRXP XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

160M

Short interest (Jul 15)

14.5%

Net Short (Jul 27 ): -0.1%

Borrow Fee

4.90%

↑ 11.3%

Available Shares

900K

↓ 9.1%

Price Chart

Company Overview

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001719406

Asset Type: CS

Market Data

Market Cap: $160,501,575

Employees: 29

Status: Active

Short Interest

Current Borrow Fee 4.90%

Range: 4.90% - 5.32%

Available Shares 900K

Range: 450K - 900K

Recent Changes

Fee Change: ↑ 11.3%

Available Change: ↑ 45.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime